Cargando…
Pharmacology of Corticosteroids for Diabetic Macular Edema
PURPOSE: Corticosteroids remain the mainstay of treatment for inflammatory diseases almost 80 years after their first clinical use. Topical ophthalmic formulations of corticosteroids have been available to treat disease of the anterior segment of the eye, but the approval of corticosteroids to treat...
Autores principales: | Whitcup, Scott M., Cidlowski, John A., Csaky, Karl G., Ambati, Jayakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961100/ https://www.ncbi.nlm.nih.gov/pubmed/29297055 http://dx.doi.org/10.1167/iovs.17-22259 |
Ejemplares similares
-
Update on corticosteroids for diabetic macular edema
por: Schwartz, Stephen G, et al.
Publicado: (2016) -
Corticosteroids for Diabetic Macular Edema
por: Chawan-Saad, Jorge, et al.
Publicado: (2019) -
Corticosteroid Treatment in Diabetic Macular Edema
por: Nurözler Tabakcı, Burcu, et al.
Publicado: (2017) -
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015) -
Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
por: Rechtman, Ehud, et al.
Publicado: (2007)